Reply to the inquiry letter on abnormal fluctuations in stock trading of Zhejiang Orient Financial Holdings Group Co.Ltd(600120) gene biological products Co., Ltd
To, Zhejiang Orient Financial Holdings Group Co.Ltd(600120) gene biological products Co., Ltd.:
We have received your confirmation letter on abnormal fluctuations in stock trading of Zhejiang Orient Financial Holdings Group Co.Ltd(600120) gene biological products Co., Ltd. as the controlling shareholder of your company, after verification, we hereby reply as follows:
Up to now, the company has no major information that should be disclosed but not disclosed, including but not limited to major events such as M & A, share issuance, debt restructuring, business restructuring, asset divestiture and asset injection under planning. (no text below this page)
Reply to the inquiry letter on abnormal fluctuations in stock trading of Zhejiang Orient Financial Holdings Group Co.Ltd(600120) gene biological products Co., Ltd
To, Zhejiang Orient Financial Holdings Group Co.Ltd(600120) gene biological products Co., Ltd.:
We have received your confirmation letter on abnormal stock trading fluctuations of Zhejiang Orient Financial Holdings Group Co.Ltd(600120) gene biological products Co., Ltd. as the actual controller of your company, after verification, we hereby reply as follows:
Up to now, the company has no major information that should be disclosed but not disclosed, including but not limited to major events such as M & A, share issuance, debt restructuring, business restructuring, asset divestiture and asset injection under planning. (no text below this page)
